| Issue | Title | Abstract | File |
| No 3 (2023) | Review and comparison of existing practices for the implementation of municipal programs of prospective public health | Abstract |
![]() (Rus) |
| Lang A.A., Mylnikova D.G. | |||
| No 13S (2018) | Review of cosmetics sales in pharmacies: 2017 results | Abstract |
![]() (Rus) |
| Nechaeva J. | |||
| No 3 (2019) | Review of Federal medicine assistance schemes | Abstract |
![]() (Rus) |
| Kovaleva K.A., Narkevich I.A., Nemyatykh .D., Vasyagina Y.A. | |||
| No 9 (2020) | Review of pharmacy sales of plasters and self-adhesive dressings | Abstract |
![]() (Rus) |
| Nechaeva Y. | |||
| No 3 (2019) | Review of PIC/S guidance on classification of GMP deficiencies | Abstract |
![]() (Rus) |
| Orlov V.A. | |||
| No 10 (2019) | Review of the Russian pharmaceutical market: results of the 1st half of 2019 | Abstract |
![]() (Rus) |
| Kalinina N. | |||
| No 1 (2021) | Reyting aptechnykh setey Rossii po itogam 2020 goda | Abstract |
![]() (Rus) |
| Bespalov N., Rasshchupkin P. | |||
| No 2 (2021) | Reyting aptechnykh setey Rossii po itogam I kvartala 2021 goda | Abstract |
![]() (Rus) |
| Bespalov N., Rasshchupkin P. | |||
| No 3 (2021) | Reyting aptechnykh setey Rossii po itogam I–II kv. 2021 goda | Abstract |
![]() (Rus) |
| Bespalov N., Rasshchupkin P. | |||
| No 7-8 (2020) | Reyting aptechnykh setey Rossiipo itogam 1-go polugodiya 2020 goda | Abstract |
![]() (Rus) |
| Bespalov N., Rasshchupkin P. | |||
| No 7-8 (2020) | Rezervy polnogo tsikla | Abstract |
![]() (Rus) |
| Kuminova E. | |||
| No 2 (2025) | Risk analysis for the quality of medicines of pharmaceutical manufacturing using a burette unit | Abstract |
![]() (Rus) |
| Voronina E.A., Vorobyeva N.V., Egorova S.N. | |||
| No 4 (2018) | Risk sharing schemes based on cost-effectiveness of multiple sclerosis disease modifying drugs: foreign experience and the possibilities of its use in Russia | Abstract |
![]() (Rus) |
| Tolkushin A.G., Kholovnya-Voloskova M.E., Andreev D.A., Khachanova N.V., Ermolaeva T.N., Davydovskaya M.V., Kokushkin K.A. | |||
| No 1 (2023) | Risk-oriented approach in the design information’s stand of pharmacies | Abstract |
![]() (Rus) |
| Gulbekova O.V., Ivanova O.V., Robertus A.I., Kolosov Y.A., Kurkin D.V., Krasheninnikov A.E., Kudrin R.A. | |||
| No 2 (2022) | Risks in the lifestyle of students | Abstract |
![]() (Rus) |
| Gureev S.A., Mingazov R.N., Sadykova R.N., Shegurova K.A. | |||
| No 11 (2018) | Road map and BAA market: forecasts and risks | Abstract |
![]() (Rus) |
| Borzova M. | |||
| No 5 (2019) | Rossiya stanet odnoy iz pervykh stran, pristupivshikh k primeneniyu innovatsionnoy vaktsiny protiv gepatita B | Abstract |
![]() (Rus) |
| Article E. | |||
| No 1-2 (2019) | Rossiyskaya kompaniya nauchila neyroset' iskat' metastazy | Abstract |
![]() (Rus) |
| Article E. | |||
| No 4 (2019) | Rossiyskie vaktsiny otsenili mezhdunarodnye eksperty | Abstract |
![]() (Rus) |
| ShIROKOVA I. | |||
| No 11-12 (2020) | Rossiyskiy farmatsevticheskiy forum o rasshirenii perechnya ZhNVLP | Abstract |
![]() (Rus) |
| Kuminova E. | |||
| No 10 (2019) | Rossiyskiy rynok implantov dlya osteosinteza | Abstract |
![]() (Rus) |
| Vanin A. | |||
| No 10 (2019) | Rossiyskiy rynok rastet blagodarya gossegmentu | Abstract |
![]() (Rus) |
| Shirokova I. | |||
| No 1-2 (2018) | Russia builds the future without tobacco | Abstract |
![]() (Rus) |
| Prozherina J., Shirokova I. | |||
| No 12 (2019) | Russia: export of FPPs at аugust-end 2019 | Abstract |
![]() (Rus) |
| - -. | |||
| No 12 (2019) | Russia: import of FPPs at аugust-end 2019 | Abstract |
![]() (Rus) |
| - -. | |||
| No 3 (2021) | Russian marketing analysis of biologically active additives with pancreatic enzyme | Abstract |
![]() (Rus) |
| Narkevich I.A., Nemyatykh O.D., Basakina I.I., Fitisova A.I. | |||
| No 4-6 (2020) | Russian pharma distributors rating at year-end 2019 | Abstract |
![]() (Rus) |
| Nechaeva Y. | |||
| No 2 (2021) | Russian pharmaceutical market as of the first quarter, 2021 | Abstract |
![]() (Rus) |
| Kalinina N., Shestovets A. | |||
| No 1 (2021) | Russian pharmaceutical market at the end of 2020 | Abstract |
![]() (Rus) |
| Kazova A., Kalinina N. | |||
| No 5 (2018) | Russian pharmaceutical market at the first quarter-end 2018 | Abstract |
![]() (Rus) |
| Denisova M., Prozerina J. | |||
| No 1-3 (2020) | Russian Pharmaceutical Market in 2019 | Abstract |
![]() (Rus) |
| Kalinina N. | |||
| No 13S (2018) | Russian pharmaceutical market: results and forecasts | Abstract |
![]() (Rus) |
| Article E. | |||
| No 3 (2019) | Russian pharmacovigilance in a newly regulated environment: two-year results and prospects | Abstract |
![]() (Rus) |
| Glagolev S.V., Gorelov K.V., Chizhova D.A. | |||
| No 10 (2020) | Russian pharmacy chains ranking based on the results for I-III Q 2020 | Abstract |
![]() (Rus) |
| Bespalov N., Rasshchupkin P. | |||
| No 5 (2018) | Rynok truda - adaptatsiya k novym vyzovam | Abstract |
![]() (Rus) |
| Shirokova I. | |||
| No 10 (2019) | Samyy moshchnyy v mire apparat MRT | Abstract |
![]() (Rus) |
| Article E. | |||
| No 3 (2023) | Satisfaction with the quality of medical care provided to adults with dental diseases under the policy of CHI and VMI: evaluation of primary reception | Abstract |
![]() (Rus) |
| Gusev A.I., Avetisyan A.K. | |||
| No 12 (2018) | Saturate the domestic market with quality products | Abstract |
![]() (Rus) |
| Prozherina J., Shirokova I. | |||
| No 3 (2022) | Scientific substantiation of the possibility of integrated interagency management in countering global biorisks for public health (by the example of the COVID-19 pandemic) | Abstract |
![]() (Rus) |
| Kaunina D.V., Vasilyev M.D. | |||
| No 13S (2018) | Segment of regional reimbursement programs | Abstract |
![]() (Rus) |
| Article E. | |||
| No 1 (2023) | Selection of criteria for the relative therapeutic value of medicines for the healthcare system | Abstract |
![]() (Rus) |
| Tolkushin A.G., Khabriev R.U. | |||
| No 12 (2018) | Sergey Akopov: «Soteks» - primer sotsial'no otvetstvennogo biznesa | Abstract |
![]() (Rus) |
| Akopov S. | |||
| No 3 (2018) | Sergey Illarioshkin: «Bolezn' Parkinsona - eto sotsial'nyy vyzov obshchestvu i meditsine» | Abstract |
![]() (Rus) |
| Article E. | |||
| No 4-6 (2020) | Server lights. Rating of Russian pharmacy chains according to the Q1 2020 results | Abstract |
![]() (Rus) |
| Bespalov N., Rasshchupkin P. | |||
| No 1-3 (2020) | Silicon raspberries. Russian pharmacy chains rating at year-end 2019 | Abstract |
![]() (Rus) |
| Bespalov N., Rasshchupkin P. | |||
| No 9 (2020) | Sistema MDLP perevoditsya na uvedomitel'nyy rezhim raboty | Abstract |
![]() (Rus) |
| Article E. | |||
| No 1 (2021) | Smart glucometers: revolution in diabetes management | Abstract |
![]() (Rus) |
| Prozherina Y. | |||
| No 4 (2025) | Socially oriented technologies used in the provision of medical care for disabled people | Abstract |
![]() (Rus) |
| Abramov N.V., Petrov A.G., Andrianova G.N. | |||
| No 3 (2025) | Socio-economic aspects of the activity of round-the-clock pharmacies | Abstract |
![]() (Rus) |
| Novokreshchenova I.G., Novokreshchenov I.V., Osipova A.V. | |||
| No 1 (2025) | Socio-economic efficiency of investments in the development of public health abroad | Abstract |
![]() (Rus) |
| Turzin P.S., Timoshevsky A.A., Derbenev D.P., Oynotkinov O.S. | |||
| No 4 (2021) | Socio-medical aspects of dental prosthetics of elderly patients who have had COVID-19 | Abstract | |
| Kopytov A.A., Volkova O.A., Ovchinnikov I.V. | |||
| No 4 (2019) | SOGLAShENIE O LOKALIZATsII V ROSSII PROIZVODSTVA TEST-SISTEMY DLYa DIAGNOSTIKI TUBERKULEZA | Abstract |
![]() (Rus) |
| - -. | |||
| No 10 (2018) | Sokhranit' ostrotu zreniya | Abstract |
![]() (Rus) |
| Bykovchenko I. | |||
| No 4 (2021) | Some aspects of the activities of the center for hygiene and epidemiology in Kazan from 2012 to 2019 | Abstract | |
| Khuzikhanov F.V., Nigmatzyanova R.R. | |||
| No 1 (2024) | Some aspects of the history of epidemics and pandemics | Abstract |
![]() (Rus) |
| Мотыгуллина Л.И., Тухбатуллина Р.Г. | |||
| No 3 (2024) | Some estimates of patient satisfaction with the quality of primary health care provided under a compulsory health insurance policy | Abstract |
![]() (Rus) |
| Gusev A.I., Adamov D.A., Zubkov V.S., Nesterenko O.L., Metelskaya A.V., Luginin P.L., Snegireva Y.Y. | |||
| No 1-2 (2018) | Sovremennaya strategiya vizualizatsii v meditsine: issledovat', izobretat', transformirovat' | Abstract |
![]() (Rus) |
| Khitrov A. | |||
| No 9 (2019) | Sovremennye tekhnologii izmenyayut prognoz bol'nykh s insul'tom. Interv'yu s Mikhailom Piradovym | Abstract |
![]() (Rus) |
| Article E. | |||
| No 4-6 (2020) | Speaking in support of patients with HIV-infection | Abstract |
![]() (Rus) |
| Prozherina Y., Shirokova I. | |||
| No 4 (2018) | Special investment contracts: reload or retuning? | Abstract |
![]() (Rus) |
| Tarasova D., Oganesyan A., Lobanov R. | |||
| No 4 (2023) | Staff and regulatory support for the profile «psychiatry-narcology» | Abstract |
![]() (Rus) |
| Schipova V.M., Umnov A.B. | |||
| No 6 (2018) | State policy in the sphere of pharmaceutics in the USSR in the 1930s | Abstract |
![]() (Rus) |
| Sherstneva E.V. | |||
| No 1-2 (2018) | State regulation of prices on medicines: search for balance | Abstract |
![]() (Rus) |
| Kopytin D.A. | |||
| No 3 (2021) | State support of export for enterprises of the medical and pharmaceutical industry | Abstract |
![]() (Rus) |
| Gertsik Y.G. | |||
| No 3 (2024) | Status of primary care within the formation of a three-level model of the health care system | Abstract |
![]() (Rus) |
| Stasevich N.Y., Smyshlyaev A.V., Gabrielyan A.R., Demuria L.E., Serov D.V. | |||
| No 6 (2018) | Sterilizatsionnoe i dezinfektsionnoe oborudovanie STEELCO i «Farmstil» - garantiya i kachestvo | Abstract |
![]() (Rus) |
| Shirokova I. | |||
| No 3 (2023) | Strategic management in the management of a medical organization | Abstract |
![]() (Rus) |
| Padiev G.B. | |||
| No 6 (2019) | Structural changes and import substitution processes in the VZN segment in 2008-2018 | Abstract |
![]() (Rus) |
| Trofimova E.O., Denisova M.N., Utomova A.S. | |||
| No 1 (2022) | Structure and staff of hospital pharmacies in the Russian Federation | Abstract | |
| Zubkov V.V., Yagudina R.I., Drokov M.Y. | |||
| No 9 (2020) | Study of main factors that lead pharmaceutical workers to change their jobs | Abstract |
![]() (Rus) |
| Dolova M.A., Yagudina R.I., Gavrilina N.I. | |||
| No 4 (2022) | Study of medicines for parenteral administration used in children's medical organization | Abstract |
![]() (Rus) |
| Abdullina Y.A., Egorova S.N., Khayatov A.R., Akhmetova T.A. | |||
| No 1 (2025) | Study of professional burnout of pharmacy workers and development of recommendations to reduce it | Abstract |
![]() (Rus) |
| Burkut A.M., Chupandina E.E., Tagintseva E.A. | |||
| No 3 (2021) | Study of the availability of gene therapeutic drugs in the Russian Federation | Abstract |
![]() (Rus) |
| Koshechkin K.A., Romanov P.A., Mokhov A.A., Khokhlov A.L. | |||
| No 4 (2021) | Study of the range of immunomodulating and immunostimulating medicines for the period from 2016 to 2021, registered in the Republic of Uzbekistan | Abstract | |
| Zuparova Z.A., Khaidarov V.R., Ismoilova G.M., Mirrakhimova T.A. | |||
| No 4 (2025) | Subjective assessment of girls' health in the context of behavioral lifestyle factors | Abstract |
![]() (Rus) |
| Bulycheva E.V., Tupikova N.N. | |||
| No 13S (2018) | Success formula of contour plus: affordability, quality and accuracy | Abstract |
![]() (Rus) |
| Article E. | |||
| No 3 (2019) | Sudebnoe reshenie v patentnom spore v pol'zu proizvoditelya original'nogo preparata | Abstract |
![]() (Rus) |
| Article E. | |||
| No 12 (2018) | Summary judicial review pertaining to the production and circulation of medical products for August-November 2018 | Abstract |
![]() (Rus) |
| Borzova M. | |||
| No 3 (2018) | Summary of court practice in the production and treatment of medical products, November 2017 - February 2018 | Abstract |
![]() (Rus) |
| Borzova M. | |||
| No 13S (2018) | Supplies of drugs produced in the EEU to Russia | Abstract |
![]() (Rus) |
| Bespalov N. | |||
| No 3 (2019) | Supplies of medicinal products manufactured in the EAEU countries to Russia | Abstract |
![]() (Rus) |
| Yutkina I. | |||
| No 1 (2021) | Surfactant therapy in combination treatment of COVID-19 related acute respiratory distress syndrome | Abstract |
![]() (Rus) |
| Gubaidullin R.R., Kuzin A.P., Kulakov V.V. | |||
| No 3 (2021) | Svetlana YuRENEVA: «V kazhdom konkretnom sluchae vrach dolzhen individual'no podkhodit' k otsenke zdorov'ya patsientki» | Abstract |
![]() (Rus) |
| - -. | |||
| No 9 (2020) | Symptomatic Slow-Acting Drugs (SYSADOA) is the new reality in the treatment of osteoarthritis | Abstract |
![]() (Rus) |
| Prozherina Y. | |||
| No 11 (2018) | Systemic juvenile arthritis: an adult disease in young patients | Abstract |
![]() (Rus) |
| Prozherina J., Ilyukhina E. | |||
| No 1-2 (2019) | Taxation of movable property - the long-awaited exemption | Abstract |
![]() (Rus) |
| Lavrentieva A. | |||
| No 2 (2023) | Team management as a factor of efficiency of a medical organization | Abstract |
![]() (Rus) |
| Padiev G.B. | |||
| No 1 (2021) | Technology and innovation in the pharmaceutical industry | Abstract |
![]() (Rus) |
| Prozherina Y. | |||
| No 4 (2025) | Telemedicine technologies as a tool for optimizing care for elderly patients | Abstract |
![]() (Rus) |
| Ktsoyev A.K., Burkovskaya Y.V. | |||
| No 3 (2019) | Telemeditsinskie resheniya - okno vozmozhnostey | Abstract |
![]() (Rus) |
| Shirokova I. | |||
| No 1 (2023) | Telepharmacy as a promising direction for the development of pharmaceutical care in the context of digital transformation | Abstract |
![]() (Rus) |
| Prosvirkin G.A., Dorofeeva V.V. | |||
| No 1 (2024) | The activities of public organizations to reduce inequality in the availability of medicines to the population. Part 1. Accessibility of medicines to the population for sustainable development | Abstract |
![]() (Rus) |
| Vrubel M.E. | |||
| No 2 (2024) | The activities of public organizations to reduce inequality in the availability of medicines to the population. Part 2. Public organizations and their role in drug provision issues | Abstract |
![]() (Rus) |
| Vrubel M.E. | |||
| No 2 (2022) | The attitude of consumers to the taste of medicines and the possibility of its correction | Abstract |
![]() (Rus) |
| Knyazeva Y.S., Kurkin D.V., Khvorostova A.S. | |||
| No 4 (2025) | The current state of the segment of industrial pharmacies with the right to manufacture aseptic drugs in the Central Federal District of Russia | Abstract |
![]() (Rus) |
| Denisova M.N., Pasko D.N., Sinitsyna A.A., Naneishvili E.G. | |||
| No 2 (2023) | The development of primary health care under the influence of the Alma-Ata and Astana declarations | Abstract |
![]() (Rus) |
| Nesterenko O.L. | |||
| No 4 (2023) | The development of the Russian pharmaceutical market at the beginning of the XXI century. Price trends and key factors. | Abstract |
![]() (Rus) |
| Denisova M.N. | |||
| No 7-8 (2020) | The electronic common technical documentformat as the basis for a single pharmaceutical market of the Eurasian Economic Union | Abstract |
![]() (Rus) |
| Taube А.А., Levashova A.Y. | |||
| No 1 (2024) | The essence and importance of academic mentoring for the professional development of students (review of foreign literature) | Abstract |
![]() (Rus) |
| Arakelyan N.L., Litvinova O.S. | |||
| No 3 (2023) | The evolution of the concept of non-interventional clinical studies | Abstract |
![]() (Rus) |
| Volskaya E.A., Vrubel M.E., Ishmuhametov A.A., Beresneva S.L. | |||
| 601 - 700 of 832 Items | << < 1 2 3 4 5 6 7 8 9 > >> | ||


